Erythroderma

Erythroderma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under: Immune System Diseases
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Triamcinolone

Resolves to

Vocabularies

MeSHT011518ICD-10L26SNOMED CT200888009MedDRA10012455UMLSC0011606

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

3Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Erythroderma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.